Download in electronic PDF format for $25



Search the Complete Journal Archives

To Flavor or Not to Flavor Extemporaneous Omeprazole Liquid

Author(s):  Chuong Monica C,Taglieri Catherine A,Kerr Stephen G

Issue:  Nov/Dec 2017 - Volume 21, Number 6
View All Articles in Issue

Abstract:  Omeprazole is a proton pump inhibitor used to treat the symptoms of gastro esophageal reflux disease, ulcers, excess stomach acid, infection with Helicobacter pylori, and to control the gastric side effects of various drugs. The approved dosage forms in the U.S. are powder in compounding kits, delayed-release granules for oral suspension, oral delayed-release tablets, and oral delayed-release capsules. An extemporaneously compounded unsweetened oral liquid method, published in the International Journal of Pharmaceutical Compounding, was found to be commonly used by pharmacists. This project investigated the robustness of the compendium omeprazole high-performance liquid chromatographic assay in evaluating an oral liquid made from commercial delayed-release pellets, the potency of extemporaneously compounded solutions having a 1.125% v/v flavored versus unflavored samples stored at controlled cold temperatures at different time points, and examining the absorption spectrum of the flavoring agent. As part of the study, stability-indication testing was also conducted. The studies indicate that the chromatographic area under the plasma concentration-time curve of both study groups remained over 90% of the label claim during the follow-up period. The flavor did not significantly impact the pH of the oral liquid. This study further identified (1) an increase in resilient foam formation in the flavored liquid, potentially hindering dosing accuracy, (2) omeprazole is oxidized easily by 3% hydrogen peroxide, and (3) flavoring agent absorbs in an ultraviolet visible spectroscopy spectral range often used in assay detectors for quantification of drug molecules, and could interfere with assay protocols of the same.

Related Keywords: Monica C. Chuong, PhD, Catherine A. Taglieri, PharmD, Stephen G. Kerr, PhD, omeprazole, proton pump inhibitors, PPIs, gastroesophageal reflux disease, GERD, Helicobacter pylori, gastric ulcers, stomach acid, gastric side effects, oral liquid preparation, foam formation, flavoring agents, stability

Related Categories: EXCIPIENTS, GASTROENTEROLOGY, PEER-REVIEWED, STABILITIES, COMPATIBILITIES, DOSAGE FORMS/DRUG CARRIERS

Printer-Friendly Version

Related Articles from IJPC
Title (Click for Abstract / Details) Author Issue Page View/Buy
To Flavor or Not to Flavor Extemporaneous Omeprazole Liquid Chuong Monica C, Taglieri Catherine A, Kerr Stephen G Nov/Dec 2017 500-512 Buy
Proton Pump Inhibitor Homogenous Suspensions: A Compounding Solution to Pediatric Gastroesophageal Reflux Disease Corsini Lindsay, Williams LaVonn A Mar/Apr 2011 124-128 Buy
Long-term Stability of Esomeprazole in 5% Dextrose Infusion Polyolefin Bags at 5°C ± 3°C after Microwave Freeze-thaw Treatment Hecq Jean-Daniel, Rolin Catherine, Godet Marie, Gillet Patricia, Jamart Jacques, Galanti Laurence M Nov/Dec 2015 521-524 Buy
Omeprazole 2-mg/mL Oral Liquid Allen Loyd V Jr Sep/Oct 2006 389 Buy
Compounded Levofloxacin Triple Therapy is Safe and Effective for Refractory Helicobacter pylori Mah Xian-Jun, Gupta Vikas, Loch Srey Neth, Ahlenstiel Golo, van de Poorten David Jul/Aug 2017 330-333 Buy
Basics of Compounding: Foam Dosage Forms Allen Loyd V Jr Jul/Aug 2013 312-322 Buy
Ranitidine Hydrochloride 15-mg/mL Oral Liquid Allen Loyd V Jr Mar/Apr 2007 161 Buy
Cimetidine 60-mg/mL Oral Liquid, Alcohol Free Allen Loyd V Jr Mar/Apr 2006 139 Buy
Pantoprazole Sodium 2-mg/mL Oral Liquid Allen Loyd V Jr Sep/Oct 2006 391 Buy
Case Report: Wound Care of a Diabetic Foot Ulcer Wynn Tom Jul/Aug 2004 265 Buy